COMPERA score revised: better risk estimation to better tailor therapeutics in precapillary hypertension.
J. Brito (Lisbon, Portugal), P. Alves Da Silva (Lisbon, Portugal), S. Couto Pereira (Lisbon, Portugal), B. Garcia (Lisbon, Portugal), J. Rigueira (Lisbon, Portugal), T. Guimarães (Lisbon, Portugal), A. G Almeida (Lisbon, Portugal), F. J Pinto (Lisbon, Portugal), R. Placido (Lisbon, Portugal)
Source: International Congress 2022 – Risk assessment in pulmonary arterial hypertension
Session: Risk assessment in pulmonary arterial hypertension
Session type: Thematic Poster
Number: 468
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Brito (Lisbon, Portugal), P. Alves Da Silva (Lisbon, Portugal), S. Couto Pereira (Lisbon, Portugal), B. Garcia (Lisbon, Portugal), J. Rigueira (Lisbon, Portugal), T. Guimarães (Lisbon, Portugal), A. G Almeida (Lisbon, Portugal), F. J Pinto (Lisbon, Portugal), R. Placido (Lisbon, Portugal). COMPERA score revised: better risk estimation to better tailor therapeutics in precapillary hypertension.. 468
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|